Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERα

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 3039-3050

  Hashimoto, Takashi ^a   Matsuda, Ken Ichi ^a   Kawata, Mitsuhiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

cell proliferation; corepressor; ER ; intranuclear mobility; nuclear matrix; SAFB; transcription

Indexed keywords

CHIMERIC PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; NUCLEAR PROTEIN; SCAFFOLD ATTACHMENT FACTOR B 1; SCAFFOLD ATTACHMENT FACTOR B 2; UNCLASSIFIED DRUG;

ARTICLE; BLEACHING; CELL FUNCTION; CELL MOTILITY; IMMUNOPRECIPITATION; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICROSCOPY, CONFOCAL; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN;

EID: 84863691443     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24182     Document Type: Article

References (46)

1. Amita M, Takahashi T, Tsutsumi S, Ohta T, Takata K, Henmi N, Hara S, Igarashi H, Takahashi K, Kurachi H,. 2009. Molecular mechanism of the inhibition of estradiol-induced endometrial Epithelial cell proliferation by clomiphene citrate. Endocrinology 151: 394-405.
2. Barrack ER,. 1987. Steroid hormone receptor localization in the nuclear matrix: Interaction with acceptor sites. J Steroid Biochem 27: 115-121.
3. Belmont A,. 2003. Dynamics of chromatin, proteins, and bodies within the cell nucleus. Curr Opin Cell Biol 15: 304-310.
4. Buttyan R, Olsson CA, Sheard B, Kallos J,. 1983. Steroid receptor-nuclear matrix interactions. J Biol Chem 258: 14366-14370.
5. Debril MB, Dubuquoy L, Fige JN, Wahli W, Desvergne B, Auwerx J, Geiman L,. 2005. Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. J Mol Endocrinol 35: 503-517.
6. DeFranco DB, Guerrero J,. 2000. Nuclear matrix targeting of steroid receptors: Specific signal sequences and acceptor proteins. Crit Rev Eukaryot Gene Expr 10: 39-44.
7. Dobrzycka KM, Townson SM, Jiang S, Oesterreich S,. 2003. Estrogen receptor corepressors-a role in human breast cancer? Endocr Relat Cancer 10: 517-536.
8. Garee JP, Oesterreich S,. 2010. SAFB1's multiple functions in biological control-lots still to be done ! J Cell Biochem 109: 312-319.
9. Graham JD, Hanson AR, Croft AJ, Fox AH, Clarke CL,. 2008. Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci. FASEB J 23: 546-556.
10. Hager GL, Nagaich AK, Johnson TA, Walker DA, John S,. 2004. Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta Gene Structure and Expression 1677: 46-51.
11. Hager GL, Elbi C, Johnson TA, Voss T, Nagaich AK, Schiltz RL, Qiu Y, John S,. 2006. Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res 14: 107-116.
12. Hager GL, Lim CS, Elbi C, Baumann CT,. 2000. Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol 74: 249-254.
13. Hager GL, McNally JG, Misteli T,. 2009. Transcription dynamics. Mol Cell 35: 741-753.
14. Hammerich-Hille S, Bardout VJ, Hilsenbeck SG, Osborne CK, Oesterreich S,. 2009. Low SAFB levels are associated with worse outcome in breast cancer patients. Breast Cancer Res Treat 121: 503-509.
15. Hart LL, Davie JR,. 2002. The estrogen receptor: More than the average transcription factor. Biochem Cell Biol 80: 335-341.
16. Htun H, Holth LT, Walker D, Davie JR, Hager GL,. 1999. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10: 471-486.
17. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S,. 2002. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29: 175-192.
18. Kawata M, Matsuda K, Nishi M, Ogawa H, Ochiai I,. 2001. Intracellular dynamics of steroid hormone receptor. Neurosci Res 40: 197-203.
19. Kino T, Liou S-H, Charmandari E, Chrousos GP,. 2006. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: Time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Mol Med 10: 80-88.
20. Kitagawa T, Matsuda KI, Inui S, Takenaka H, Katoh N, Itami S, Kishimoto S, Kawata M,. 2009. Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells. J Clin Endocr Metab 94: 1288-1294.
21. Maruvada P,. 2002. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biological Chem 278: 12425-12432.
22. Maruyama K, Endoh H, Sasaki-Iwaoka H, Kanou H, Shimaya E, Hashimoto S, Kato S, Kawashima H,. 1998. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. Biochem Biophys Res Commun 246: 142-147.
23. Matsuda K, Nishi M, Takaya H, Kaku N, Kawata M,. 2008. Intranuclear mobility of estrogen receptor α and progesterone receptors in association with nuclear matrix dynamics. J Cell Biochem 103: 136-148.
24. Matsuda K, Ochiai I, Nishi M, Kawata M,. 2002. Colocalization and ligand-dependent discrete distribution of the estrogen receptor (ER)alpha and ERbeta. Mol Endocrinol 16: 2215-2230.
25. McKenna NJ, Lanz RB, O'Malley BW,. 1999. Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev 20: 321-344.
26. McNally JG, Muller WG, Walker D, Wolford R, Hager GL,. 2000. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287: 1262-1265.
27. Miller BJ, Wang D, Krahe R, Wright FA,. 2003. Pooled analysis of loss of heterozygosity in breast cancer: A genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet 73: 748-767.
28. Moggs JG, Orphanides G,. 2001. Estrogen receptors: Orchestrators of pleiotropic cellular responses. EMBO Rep 2: 775-781.
29. Ochiai I, Matsuda K, Nishi M, Ozawa H, Kawata M,. 2003. Imaging analysis of subcellular correlation of androgen receptor and estrogen receptor in single living cells using green fluorescent protein color variants. Mol Endocrinol 18: 26-42.
30. Oesterreich S,. 2003. Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis? J Cell Biochem 90: 653-661.
31. Oesterreich S, Allredl DC, Mohsin SK, Zhang Q, Wong H, Lee AV, Osborne CK, O'Connell P,. 2001. High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer. Br J Cancer 84: 493-498.
32. Osborne CK, Schiff R, Fuqua SA, Shou J,. 2001. Estrogen receptor: Current understanding of its activation and modulation. Clin Cancer Res 7: 4338s-4342s; discussion 4411s-4412s.
33. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL,. 2005. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25: 2406-2418.
34. Schaaf MJ, Cidlowski JA,. 2003. Molecular determinants of glucocorticoid receptor mobility in living cells: The importance of ligand affinity. Mol Cell Biol 23: 1922-1934.
35. Sergeant KA, Bourgeois CF, Dalgliesh C, Venables JP, Stevenin J, Elliott DJ,. 2007. Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2. J Cell Sci 120: 309-319.
36. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA,. 2000. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol 14: 518-534.
37. Stenoien DL, Nye AC, Mancini MG, Patel K, Dutertre M, O'Malley BW, Smith CL, Belmont AS, Mancini MA,. 2001a. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells. Mol Cell Biol 21: 4404-4412.
38. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA,. 2001b. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol 3: 15-23.
39. Townson SM, Dobrzycka KM, Lee AV, Air M, Deng W, Kang K, Jiang S, Kioka N, Michaelis K, Oesterreich S,. 2003. SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor. J Biol Chem 278: 20059-20068.
40. Townson SM, Kang K, Lee AV, Oesterreich S,. 2004. Structure-function analysis of the estrogen receptor corepressor scaffold attachment factor-B1: Identification of a potent transcriptional repression domain. J Biol Chem 279: 26074-26081.
41. Townson SM, Sullivan T, Zhang Q, Clark GM, Osborne CK, Lee AV, Oesterreich S,. 2000. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. Clin Cancer Res 6: 3788-3796.
42. Tsutsui KM, Sano K, Tsutsui K,. 2005. Dynamic view of the nuclear matrix. Acta Med Okayama 59: 113-120.
43. van Steensel B, Jenster G, Damm K, Brinkmann AO, van Driel R,. 1995. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J Cell Biochem 57: 465-478.
44. Verheijen R, van Venrooij W, Ramaekers F,. 1988. The nuclear matrix: Structure and composition. J Cell Sci 90 (Pt 1): 11-36.
45. Wu Y, Kawate H, Ohnaka K, Nawata H, Takayanagi R,. 2006. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Mol Cell Biol 26: 6633-6655.
46. Zhao Y-y, Guo L, Zhao X-j, Liu H, Lei T, Ma D-j, Gao X-y,. 2009. Transcriptional activation of insulin-like growth factor binding protein 6 by 17β-estradiol in SaOS-2 cells. Exp Mol Med 41: 478-486.